drugset / Trial / NCT00173745

Treatment of Drooling With Type A Botulinum Toxin in Children With Cerebral Palsy

NCT00173745

RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to evaluate the effectiveness of botulinum toxin injection to treat drooling in children with cerebral palsy, and to find the most appropriate dosage, duration of effect and side effects.

Timeline

Start
2003-06
Primary completion
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic

Indications